Tender detail
Aflibercept discount agreements 2026–24
Summary
TK is seeking to conclude discount agreements with pharmaceutical companies for the active ingredient aflibercept (ATC S01LA05, strength 40 mg/ml). The agreements run for up to 12 months from 1 August 2026, end no later than 31 July 2027, and may be extended by 12 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.